Delivery Order SPE2DB22D1202-SPE2DB24FUPN1
Award Date
2/2/24
Potential Completion Date
2/5/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order under an Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corporation's Corporate Office division. The $3,221.03 firm fixed price contract is for the delivery of Exforge 5-160 mg tablets, a prescription medication. The award is not set aside and is part of Amerisourcebergen's broader IDC with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables...
This federal contract award is for the delivery of Exforge 10-160 mg tablets, a cardiovascular medication, to the Defense Logistics Agency (DLA). The $1,812.58 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 24, 2024. The contract has an ultimate completion date of October 25, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $15,834.87, is a Delivery Order contract for Exforge 10-320 mg tablets. The contract has an ultimate completion date of October 31, 2024 and a firm fixed price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,548.75 firm-fixed-price delivery order is for EXFORGE 5-320 MG TABLET 30S, a cardiovascular medication. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,042.14 firm fixed-price delivery order is for the supply of Exforge 5-160 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of December 8, 2022 and was awarded on December 7, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of various medical products and prescription medications. The contract, valued at $1,326.66, is a firm fixed-price delivery order that covers the provision of Exforge 5-320 mg tablets. The award has no set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Exforge in 5-160 mg tablet form. The contract has a ceiling value of $1,491.79 and a period of performance through March 22, 2023. This is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of pharmaceutical products, specifically Exforge tablets. The delivery order, valued at $1,504.44, has a period of performance ending on September 16, 2024. It is placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, which serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply EXFORGE 10-160 mg tablets. The $2,665.30 firm fixed price contract has an ultimate completion date of October 28, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,358.56 firm fixed-price delivery order is for the supply of EXFORGE 5-160 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of November 1, 2023 and was awarded on October 31, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...